Literature DB >> 15307179

NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation.

Yeonseok Chung1, Woo-Sung Chang, Sanghee Kim, Chang-Yuil Kang.   

Abstract

NKT cells play contradictory roles in vivo, both regulating autoimmunity and activating immunity to intracellular pathogens and tumors. In this study, we studied the effect of NKT cell activation on the induction of systemic tolerance by oral administration of antigen. Administration of alpha-galactosylceramide (alphaGC) at the time of oral ovalbumin (OVA) feeding completely blocked the OVA-specific tolerance induced by both high- and low-dose regimens in BALB/c mice. In the mesenteric lymph nodes (MLN) of alphaGC-treated mice, the proliferation of OVA-specific T cells was greater than that seen in the MLN of vehicle-treated mice in vivo. The administration of alphaGC triggered the full maturation of mesenteric dendritic cells (DC), which were in turn responsible for the enhanced division of OVA-specific T cells in vitro. To further determine whether the costimulation provided by DC in alphaGC-treated mice was responsible for the reversal of oral tolerance in vivo, mice were given alphaGC together with anti-CD80 and anti-CD86 blocking Ab. OVA-specific systemic tolerance was restored in mice given the blocking Ab, even when they simultaneously received alphaGC. Therefore, oral tolerance can be reversed via costimulation by DC that have been triggered to fully mature by the administration of alphaGC. Copyright 2004 Wiley-VCH Verlag GmbH & Co.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307179     DOI: 10.1002/eji.200425027

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells.

Authors:  Hyun Jung Kim; Su Jin Hwang; Byoung Kwon Kim; Kyeong Cheon Jung; Doo Hyun Chung
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Harnessing invariant NKT cells in vaccination strategies.

Authors:  Vincenzo Cerundolo; Jonathan D Silk; S Hajar Masri; Mariolina Salio
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

3.  Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.

Authors:  Carole Guillonneau; Justine D Mintern; François-Xavier Hubert; Aeron C Hurt; Gurdyal S Besra; Steven Porcelli; Ian G Barr; Peter C Doherty; Dale I Godfrey; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

4.  Characteristics of Schistosoma japonicum infection induced IFN-γ and IL-4 co-expressing plasticity Th cells.

Authors:  Dianhui Chen; Hongyan Xie; Hefei Cha; Jiale Qu; Mei Wang; Lu Li; Sifei Yu; Changyou Wu; Xiaoping Tang; Jun Huang
Journal:  Immunology       Date:  2016-09       Impact factor: 7.397

5.  Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.

Authors:  Aurore Miellot-Gafsou; Jérôme Biton; Elvire Bourgeois; André Herbelin; Marie-Christophe Boissier; Natacha Bessis
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

6.  Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Xiangming Li; Masakazu Fujio; Masakazu Imamura; Douglass Wu; Sandhya Vasan; Chi-Huey Wong; David D Ho; Moriya Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-02       Impact factor: 11.205

7.  Changes in NK and NKT cells in mesenteric lymph nodes after a Schistosoma japonicum infection.

Authors:  Xueping Luo; Hongyan Xie; Dianhui Chen; Xiuxue Yu; Fan Wu; Lu Li; Changyou Wu; Jun Huang
Journal:  Parasitol Res       Date:  2013-12-10       Impact factor: 2.289

Review 8.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.

Authors:  Yeonseok Chung; Hong Qin; Chang-Yuil Kang; Sanghee Kim; Larry W Kwak; Chen Dong
Journal:  Blood       Date:  2007-06-20       Impact factor: 22.113

10.  Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells.

Authors:  Subramanya Hegde; Ewa Jankowska-Gan; Drew A Roenneburg; Jose Torrealba; William J Burlingham; Jenny E Gumperz
Journal:  J Leukoc Biol       Date:  2009-10       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.